专题：Neutropenia and Cancer Infections

This cluster of papers focuses on the management of febrile neutropenia in cancer patients, particularly those with hematological malignancies receiving chemotherapy. It includes clinical practice guidelines, updates on antimicrobial agents, use of granulocyte colony-stimulating factor, risk assessment tools, prophylactic strategies, and the impact of febrile neutropenia on morbidity and mortality.
最新文献
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

article Full Text OpenAlex

Intratumoral bacterial abundance confers poor response to adjuvant gemcitabine in resected pancreatic cancer patients which is mitigated by postoperative antibiotics

article Full Text OpenAlex

Negative Effect of Intravenous Antibiotics on Survival in Patients with Triple-Negative Breast Cancer

article Full Text OpenAlex

Preventing pneumococcal infections in patients with hematological malignancies: a review of evidence and recommendations based on modified Delphi consensus

review Full Text OpenAlex

Oral Management Improves Patient Outcomes in Hematopoietic Stem Cell Transplantation

article Full Text OpenAlex

Tolerance for chemotherapy-induced peripheral neuropathy among women with metastatic breast cancer: a discrete-choice experiment

article Full Text OpenAlex

Metagenomic Next-generation Sequencing Compared With Blood Culture as First-line Diagnostic Method for Bloodstream Infection in Hematologic Patients With Febrile Neutropenia: A Multicenter, Prospective Study

article Full Text OpenAlex

Advances in the Treatment of Acute Myeloid Leukemia: Implications for Low- and Middle-Income Countries

review Full Text OpenAlex

Long-term mortality in ICU patients with hematological malignancies: Impact of organ support duration and ICU length of stay

article Full Text OpenAlex

Diagnosis and management of neutropenia

review Full Text OpenAlex

近5年高被引文献
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

article Full Text OpenAlex 708 FWCI53.8833877

Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer

article Full Text OpenAlex 308 FWCI45.8811261

Sepsis-Induced Immunosuppression

review Full Text OpenAlex 288 FWCI40.69597198

De novo acute myeloid leukemia: A population‐based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017

article Full Text OpenAlex 244 FWCI32.30416851

CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial

article Full Text OpenAlex 185 FWCI24.87792287

8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation

review Full Text OpenAlex 184 FWCI10.31326185

The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis

review Full Text OpenAlex 184 FWCI29.19708025

Antibiotics and Chemotherapy

article Full Text OpenAlex 176 FWCI0

Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward

review Full Text OpenAlex 167 FWCI12.89427371

Estimation of the Number of Individuals Living With Metastatic Cancer in the United States

article Full Text OpenAlex 162 FWCI24.72813939